Invitrogen™ Tiragolumab Humanized Recombinant Human Monoclonal Antibody

Human Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA542170

Catalog No. PIMA542170

Description

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Tiragolumab is a humanized monoclonal antibody. Tiragolumab targets TIGIT and directly or indirectly activates the anti-tumor immune response by acting on the activation pathways of APC and T cells and NK cells to achieve the purpose of eliminating tumor cells.

Specifications

• Antigen: Tiragolumab Humanized
• Classification: Recombinant Monoclonal
• Conjugate: Unconjugated
• Gene Alias: MTIG7192A; MTIG-7192A; MTIG-7192-A; RG-6058; RO7092284; RO-7092284
• Immunogen: Human TIGIT/VSIG9/VSTM3.
• Quantity: 100 μg
• Primary or Secondary: Primary
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Liquid
• Target Molecule: Chemical

• Applications: ELISA, SDS-Page
• Concentration: 2.6 mg/mL
• Formulation: PBS with no preservative; pH 7.4
• Host Species: Human
• Purification Method: Protein A
• Regulatory Status: RUO
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG1 κ

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov